{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:46:03Z","timestamp":1781361963425,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The heparan sulfate endoglycosidase heparanase (HPSE) is involved in tumor growth, chronic inflammation and fibrosis. Since a role for HPSE in chronic liver disease has not been demonstrated to date, the current study was aimed at investigating the involvement of HPSE in the pathogenesis of chronic liver injury. Herein, we revealed that HPSE expression increased in mouse livers after carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>)-mediated chronic induction of fibrosis, but with a trend to decline during progression of the disease. In mouse fibrotic liver tissues HPSE immunostaining was restricted in necro-inflammatory areas, co-localizing with F4\/80 macrophage marker and TNF-\u03b1. TNF-\u03b1 treatment induced HPSE expression as well as HPSE secretion in U937 macrophages. Moreover, macrophage-secreted HPSE regulated the expression of \u03b1-SMA and fibronectin in hepatic stellate LX-2 cells. Finally, HPSE activity increased in the plasma of patients with liver fibrosis but it inversely correlated with liver stiffness. Our results suggest the involvement of HPSE in early phases of reaction to liver damage and inflammatory macrophages as an important source of HPSE. HPSE seems to play a key role in the macrophage-mediated activation of hepatic stellate cells (HSCs), thus suggesting that HPSE targeting could be a new therapeutic option in the treatment of liver fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-017-14946-0","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T11:33:08Z","timestamp":1509103988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Heparanase and macrophage interplay in the onset of liver fibrosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Maria Francesca","family":"Secchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Masola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-7418","authenticated-orcid":false,"given":"Maurizio","family":"Onisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"14946_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature reviews. Immunology \n                           14, 181\u2013194, https:\/\/doi.org\/10.1038\/nri3623 (2014).","journal-title":"Nature reviews. Immunology"},{"key":"14946_CR2","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","volume":"20","author":"GO Elpek","year":"2014","unstructured":"Elpek, G. O. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World journal of gastroenterology \n                           20, 7260\u20137276, https:\/\/doi.org\/10.3748\/wjg.v20.i23.7260 (2014).","journal-title":"World journal of gastroenterology"},{"key":"14946_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche, J. E., Saiman, Y. & Friedman, S. L. Hepatic stellate cells and liver fibrosis. Comprehensive Physiology \n                           3, 1473\u20131492, https:\/\/doi.org\/10.1002\/cphy.c120035 (2013).","journal-title":"Comprehensive Physiology"},{"key":"14946_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c120026","volume":"3","author":"LJ Dixon","year":"2013","unstructured":"Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T. & Nagy, L. E. Kupffer cells in the liver. Comprehensive Physiology \n                           3, 785\u2013797, https:\/\/doi.org\/10.1002\/cphy.c120026 (2013).","journal-title":"Comprehensive Physiology"},{"key":"14946_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","volume":"11","author":"V Vreys","year":"2007","unstructured":"Vreys, V. & David, G. Mammalian heparanase: what is the message? Journal of cellular and molecular medicine \n                           11, 427\u2013452, https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00039.x (2007).","journal-title":"Journal of cellular and molecular medicine"},{"key":"14946_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1515\/bmc-2015-0021","volume":"6","author":"MF Secchi","year":"2015","unstructured":"Secchi, M. F. et al. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. Biomolecular concepts \n                           6, 415\u2013421, https:\/\/doi.org\/10.1515\/bmc-2015-0021 (2015).","journal-title":"Biomolecular concepts"},{"key":"14946_CR7","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00018-008-7584-6","volume":"65","author":"NJ Nasser","year":"2008","unstructured":"Nasser, N. J. Heparanase involvement in physiology and disease. Cellular and molecular life sciences: CMLS \n                           65, 1706\u20131715, https:\/\/doi.org\/10.1007\/s00018-008-7584-6 (2008).","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"14946_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4155\/fmc-2016-0012","volume":"8","author":"S Rivara","year":"2016","unstructured":"Rivara, S., Milazzo, F. M. & Giannini, G. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases. Future medicinal chemistry \n                           8, 647\u2013680, https:\/\/doi.org\/10.4155\/fmc-2016-0012 (2016).","journal-title":"Future medicinal chemistry"},{"key":"14946_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/febs.13932","volume":"284","author":"RD Sanderson","year":"2017","unstructured":"Sanderson, R. D., Elkin, M., Rapraeger, A. C., Ilan, N. & Vlodavsky, I. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy. The FEBS journal \n                           284, 42\u201355, https:\/\/doi.org\/10.1111\/febs.13932 (2017).","journal-title":"The FEBS journal"},{"key":"14946_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.ASN.0000103229.25389.40","volume":"15","author":"V Levidiotis","year":"2004","unstructured":"Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M. E. & Power, D. A. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. Journal of the American Society of Nephrology: JASN \n                           15, 68\u201378 (2004).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"14946_CR11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/sj.ki.5001985","volume":"70","author":"MJ van den Hoven","year":"2006","unstructured":"van den Hoven, M. J. et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney international \n                           70, 2100\u20132108, https:\/\/doi.org\/10.1038\/sj.ki.5001985 (2006).","journal-title":"Kidney international"},{"key":"14946_CR12","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1097\/01.ASN.0000142426.55612.6D","volume":"15","author":"V Levidiotis","year":"2004","unstructured":"Levidiotis, V. et al. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. Journal of the American Society of Nephrology: JASN \n                           15, 2882\u20132892, https:\/\/doi.org\/10.1097\/01.asn.0000142426.55612.6d (2004).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"14946_CR13","doi-asserted-by":"publisher","unstructured":"Rabelink, T. J. et al. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease. Nature reviews. Nephrology, doi:https:\/\/doi.org\/10.1038\/nrneph.2017.6 (2017).","DOI":"10.1038\/nrneph.2017.6"},{"issue":"Suppl 2","key":"14946_CR14","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/S0049-3848(14)50015-1","volume":"133","author":"Y Nadir","year":"2014","unstructured":"Nadir, Y. & Brenner, B. Heparanase multiple effects in cancer. Thrombosis research \n                           133(Suppl 2), S90\u201394, https:\/\/doi.org\/10.1016\/s0049-3848(14)50015-1 (2014).","journal-title":"Thrombosis research"},{"key":"14946_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1568009614666140224155124","volume":"14","author":"V Masola","year":"2014","unstructured":"Masola, V., Secchi, M. F., Gambaro, G. & Onisto, M. Heparanase as a target in cancer therapy. Current cancer drug targets \n                           14, 286\u2013293 (2014).","journal-title":"Current cancer drug targets"},{"key":"14946_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","volume":"29","author":"I Vlodavsky","year":"2016","unstructured":"Vlodavsky, I. et al. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy \n                           29, 54\u201375, https:\/\/doi.org\/10.1016\/j.drup.2016.10.001 (2016).","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"14946_CR17","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1172\/JCI43792","volume":"121","author":"I Lerner","year":"2011","unstructured":"Lerner, I. et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. The Journal of clinical investigation \n                           121, 1709\u20131721, https:\/\/doi.org\/10.1172\/jci43792 (2011).","journal-title":"The Journal of clinical investigation"},{"key":"14946_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gutjnl-2014-308048","volume":"64","author":"E Shimshoni","year":"2015","unstructured":"Shimshoni, E., Yablecovitch, D., Baram, L., Dotan, I. & Sagi, I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut \n                           64, 367\u2013372, https:\/\/doi.org\/10.1136\/gutjnl-2014-308048 (2015).","journal-title":"Gut"},{"key":"14946_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0962-8924(00)01897-3","volume":"11","author":"J Turnbull","year":"2001","unstructured":"Turnbull, J., Powell, A. & Guimond, S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends in cell biology \n                           11, 75\u201382 (2001).","journal-title":"Trends in cell biology"},{"key":"14946_CR20","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1111\/j.1742-4658.2010.07798.x","volume":"277","author":"T Manon-Jensen","year":"2010","unstructured":"Manon-Jensen, T., Itoh, Y. & Couchman, J. R. Proteoglycans in health and disease: the multiple roles of syndecan shedding. The FEBS journal \n                           277, 3876\u20133889, https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07798.x (2010).","journal-title":"The FEBS journal"},{"key":"14946_CR21","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1074\/jbc.M111.279836","volume":"287","author":"V Masola","year":"2012","unstructured":"Masola, V. et al. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. The Journal of biological chemistry \n                           287, 1478\u20131488, https:\/\/doi.org\/10.1074\/jbc.M111.279836 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"14946_CR22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.bbamcr.2014.06.005","volume":"1843","author":"V Masola","year":"2014","unstructured":"Masola, V. et al. Heparanase is a key player in renal fibrosis by regulating TGF-beta expression and activity. Biochimica et biophysica acta \n                           1843, 2122\u20132128, https:\/\/doi.org\/10.1016\/j.bbamcr.2014.06.005 (2014).","journal-title":"Biochimica et biophysica acta"},{"key":"14946_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2337\/db11-1024","volume":"61","author":"N Gil","year":"2012","unstructured":"Gil, N. et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes \n                           61, 208\u2013216, https:\/\/doi.org\/10.2337\/db11-1024 (2012).","journal-title":"Diabetes"},{"key":"14946_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1386-6346(03)00107-4","volume":"26","author":"Y Xiao","year":"2003","unstructured":"Xiao, Y., Kleeff, J., Shi, X., Buchler, M. W. & Friess, H. Heparanase expression in hepatocellular carcinoma and the cirrhotic liver. Hepatology research: the official journal of the Japan Society of Hepatology \n                           26, 192\u2013198 (2003).","journal-title":"Hepatology research: the official journal of the Japan Society of Hepatology"},{"key":"14946_CR25","first-page":"1299","volume":"7","author":"ON El-Assal","year":"2001","unstructured":"El-Assal, O. N., Yamanoi, A., Ono, T., Kohno, H. & Nagasue, N. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research \n                           7, 1299\u20131305 (2001).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"14946_CR26","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.3748\/wjg.v20.i32.11384","volume":"20","author":"CJ Liu","year":"2014","unstructured":"Liu, C. J. et al. Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence. World journal of gastroenterology \n                           20, 11384\u201311393, https:\/\/doi.org\/10.3748\/wjg.v20.i32.11384 (2014).","journal-title":"World journal of gastroenterology"},{"key":"14946_CR27","doi-asserted-by":"crossref","unstructured":"Ikeguchi, M., Hirooka, Y. & Kaibara, N. Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma. European journal of cancer (Oxford, England: 1990) \n                           39, 86\u201390 (2003).","DOI":"10.1016\/S0959-8049(02)00558-0"},{"key":"14946_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/path.1554","volume":"203","author":"O Goldshmidt","year":"2004","unstructured":"Goldshmidt, O. et al. Heparanase expression during normal liver development and following partial hepatectomy. The Journal of pathology \n                           203, 594\u2013602, https:\/\/doi.org\/10.1002\/path.1554 (2004).","journal-title":"The Journal of pathology"},{"key":"14946_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/labinvest.2008.30","volume":"88","author":"O Ohayon","year":"2008","unstructured":"Ohayon, O. et al. Halofuginone upregulates the expression of heparanase in thioacetamide-induced liver fibrosis in rats. Laboratory investigation; a journal of technical methods and pathology \n                           88, 627\u2013633, https:\/\/doi.org\/10.1038\/labinvest.2008.30 (2008).","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"14946_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-011-1016-x","volume":"359","author":"Y Zhao","year":"2012","unstructured":"Zhao, Y. et al. Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44\/42 mitogen-activated protein kinase\/cyclooxygenase-2 pathway. Molecular and cellular biochemistry \n                           359, 217\u2013223, https:\/\/doi.org\/10.1007\/s11010-011-1016-x (2012).","journal-title":"Molecular and cellular biochemistry"},{"key":"14946_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1158\/0008-5472.CAN-05-1811","volume":"66","author":"A Zetser","year":"2006","unstructured":"Zetser, A. et al. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer research \n                           66, 1455\u20131463, https:\/\/doi.org\/10.1158\/0008-5472.can-05-1811 (2006).","journal-title":"Cancer research"},{"key":"14946_CR32","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1167\/iovs.11-9144","volume":"53","author":"J Hu","year":"2012","unstructured":"Hu, J. et al. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization. Investigative ophthalmology & visual science \n                           53, 6810\u20136817, https:\/\/doi.org\/10.1167\/iovs.11-9144 (2012).","journal-title":"Investigative ophthalmology & visual science"},{"key":"14946_CR33","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1111\/febs.12184","volume":"280","author":"A Meirovitz","year":"2013","unstructured":"Meirovitz, A. et al. Heparanase in inflammation and inflammation-associated cancer. The FEBS journal \n                           280, 2307\u20132319, https:\/\/doi.org\/10.1111\/febs.12184 (2013).","journal-title":"The FEBS journal"},{"key":"14946_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0538-5","volume":"13","author":"V Masola","year":"2015","unstructured":"Masola, V., Zaza, G., Onisto, M., Lupo, A. & Gambaro, G. Impact of heparanase on renal fibrosis. Journal of translational medicine \n                           13, 181, https:\/\/doi.org\/10.1186\/s12967-015-0538-5 (2015).","journal-title":"Journal of translational medicine"},{"key":"14946_CR35","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.2337\/db14-0001","volume":"63","author":"R Goldberg","year":"2014","unstructured":"Goldberg, R. et al. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Diabetes \n                           63, 4302\u20134313, https:\/\/doi.org\/10.2337\/db14-0001 (2014).","journal-title":"Diabetes"},{"key":"14946_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/modpathol.3800710","volume":"20","author":"M Waterman","year":"2007","unstructured":"Waterman, M. et al. Heparanase upregulation by colonic epithelium in inflammatory bowel disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc \n                           20, 8\u201314, https:\/\/doi.org\/10.1038\/modpathol.3800710 (2007).","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"14946_CR37","doi-asserted-by":"publisher","unstructured":"Tan, Z. et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. Journal of immunology (Baltimore, M. d.: 1950) 191, 1835\u20131844, doi:https:\/\/doi.org\/10.4049\/jimmunol.1203013 (2013).","DOI":"10.4049\/jimmunol.1203013"},{"key":"14946_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jhep.2013.12.005","volume":"60","author":"A Moles","year":"2014","unstructured":"Moles, A. et al. A TLR2\/S100A9\/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. Journal of hepatology \n                           60, 782\u2013791, https:\/\/doi.org\/10.1016\/j.jhep.2013.12.005 (2014).","journal-title":"Journal of hepatology"},{"key":"14946_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.surg.2008.01.008","volume":"143","author":"MW Harty","year":"2008","unstructured":"Harty, M. W. et al. Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery \n                           143, 667\u2013678, https:\/\/doi.org\/10.1016\/j.surg.2008.01.008 (2008).","journal-title":"Surgery"},{"key":"14946_CR40","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2353\/ajpath.2010.090527","volume":"176","author":"MW Harty","year":"2010","unstructured":"Harty, M. W. et al. Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers. The American journal of pathology \n                           176, 1271\u20131281, https:\/\/doi.org\/10.2353\/ajpath.2010.090527 (2010).","journal-title":"The American journal of pathology"},{"key":"14946_CR41","doi-asserted-by":"publisher","unstructured":"Davids, J. S., Carothers, A. M., Damas, B. C. & Bertagnolli, M. M. Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis. Cancer prevention research (Philadelphia, Pa.) \n                           3, 348\u2013358, doi:https:\/\/doi.org\/10.1158\/1940-6207.capr-09-0146 (2010).","DOI":"10.1158\/1940-6207.capr-09-0146"},{"key":"14946_CR42","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke, F. & Zimmermann, H. W. Macrophage heterogeneity in liver injury and fibrosis. Journal of hepatology \n                           60, 1090\u20131096, https:\/\/doi.org\/10.1016\/j.jhep.2013.12.025 (2014).","journal-title":"Journal of hepatology"},{"key":"14946_CR43","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1021\/bi0356552","volume":"43","author":"G Chen","year":"2004","unstructured":"Chen, G. et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry \n                           43, 4971\u20134977, https:\/\/doi.org\/10.1021\/bi0356552 (2004).","journal-title":"Biochemistry"},{"key":"14946_CR44","doi-asserted-by":"publisher","first-page":"e109596","DOI":"10.1371\/journal.pone.0109596","volume":"9","author":"KJ Goodall","year":"2014","unstructured":"Goodall, K. J., Poon, I. K., Phipps, S. & Hulett, M. D. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4. PloS one \n                           9, e109596, https:\/\/doi.org\/10.1371\/journal.pone.0109596 (2014).","journal-title":"PloS one"},{"key":"14946_CR45","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","volume":"33","author":"M Blich","year":"2013","unstructured":"Blich, M. et al. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression. Arteriosclerosis, thrombosis, and vascular biology \n                           33, e56\u201365, https:\/\/doi.org\/10.1161\/atvbaha.112.254961 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"14946_CR46","doi-asserted-by":"publisher","first-page":"E7808","DOI":"10.1073\/pnas.1611380113","volume":"113","author":"L Gutter-Kapon","year":"2016","unstructured":"Gutter-Kapon, L. et al. Heparanase is required for activation and function of macrophages. Proceedings of the National Academy of Sciences of the United States of America \n                           113, E7808\u2013E7817, https:\/\/doi.org\/10.1073\/pnas.1611380113 (2016).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"14946_CR47","doi-asserted-by":"publisher","unstructured":"Zaza, G. et al. Dialysis-related transcriptomic profiling: the pivotal role of heparanase. Experimental biology and medicine (Maywood, N. J.) \n                           239, 52\u201364, doi:https:\/\/doi.org\/10.1177\/1535370213506678 (2014).","DOI":"10.1177\/1535370213506678"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14946-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:05:46Z","timestamp":1671800746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14946"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14946-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14956"}}